Abits
ABTS
Bakkt Holdings
BKKT
Riot Platforms
RIOT
Canaan
CAN
CATHEDRA BITCOIN INC
CBTTF
US Stock MarketDetailed Quotes
AXSM Axsome Therapeutics
- 90.100
- -4.270-4.52%
Close Dec 13 16:00 ET
- 89.110
- -0.990-1.10%
Pre 06:12 ET
4.37BMarket Cap-13.69P/E (TTM)
94.685High89.800Low581.58KVolume94.010Open94.370Pre Close53.07MTurnover1.61%Turnover RatioLossP/E (Static)48.46MShares105.00052wk High47.00P/B3.27BFloat Cap64.11052wk Low--Dividend TTM36.24MShs Float109.940Historical High--Div YieldTTM5.18%Amplitude1.940Historical Low91.249Avg Price1Lot Size
Axsome Therapeutics News
Axsome Therapeutics | 8-K: Current report
Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Coleman Mark
Axsome Therapeutics | 8-K: Axsome Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Axsome Therapeutics | 10-Q: Q3 2024 Earnings Report
Axsome Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Maizel Ari
Axsome Therapeutics | 8-K: Current report
Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Saad Mark E
Axsome Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Axsome Therapeutics | 8-K: Current report
Axsome Therapeutics | 8-K: Current report
Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jacobson Mark L.
Axsome Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Axsome Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Axsome Therapeutics | 10-Q: Q2 2024 Earnings Report
Axsome Therapeutics | 8-K: Axsome Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
Axsome Therapeutics | 8-K: Current report
Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Mahony Susan
Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Coleman Mark
Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director JEFFS ROGER
Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Saad Mark E
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.